The rationale has been drawn from higher urinary NGAL concentrations in patients with renal involvement (as opposed to non-renal MM), correlations with eGFR and urinary FLC, and greater sensitivity for renal injury over serum NGAL [36]. The gene discussed is LCN2; the disease is Miyoshi myopathy.